ExeVir
exevir.com
Actively hiring
Public Health & Prevention
Infectious Disease Therapeutics
Drug Discovery
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
2
Fund+, V-Bio Ventures
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Registers and programsofficial lists and records that name the company
| Legal entity | ADDRESS Exevir Bio BV | its site |
Backed byfrom the funds' portfolios and accelerator catalogs
Fund+ 
V-Bio Ventures Similar startupsby what they do, their industry and backers
T cell Based Immunotherapies for Cancer and Chronic Infectious Diseases.
Paratek Pharmaceuticals is committed to developing and delivering innovative treatments for serious infectious diseases. Learn about our…
Intelligent Automation-Powered Precision Medicines Engineering bacteriophage therapies for infectious diseases and immunology See How…
TareBio develops vaccines for cancer and infectious diseases by decoding immune responses to engineer targeted antigens.
Our Mission and Innovation We are a biotechnology pioneer dedicated to solving one of the greatest challenges in modern medicine: the…
From pharmaceutical and life science innovators to healthcare systems and government agencies, Biobot provides population-level…
News
Report
ExeVir Announces Michael Garrett as New Chief Executive Officer
Company developing antibody therapeutics against emerging viral threatsMichel The post ExeVir Announces Michael Garrett as New Chief Executive Officer appeared first on ExeVir.
Read more
Report
Poster ID Week 2024
Poster presented by Florence Herschke at ID Week 2024, October 16-19, 2024, Los Angeles, USA The post Poster ID Week 2024 appeared first on ExeVir.
Read more
Report
Empowering the Immunocompromised and Elderly: ExeVir Bio presents promising XVR013m data at ID Week 2024
media439244
Read more
Report
Empowering the Immunocompromised and Elderly: ExeVir Bio presents promising XVR013m data at ID Week 2024
The post Empowering the Immunocompromised and Elderly: ExeVir Bio presents promising XVR013m data at ID Week 2024 appeared first on ExeVir.
Read more
Report
Pro access
Upgrade to see all 18 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.